121 related articles for article (PubMed ID: 26240223)
1. Reply to Z. Li et al.
Fang S; Wang Y; Amos CI; Lee JE
J Clin Oncol; 2015 Nov; 33(31):3674-5. PubMed ID: 26240223
[No Abstract] [Full Text] [Related]
2. Is C-Reactive Protein a Specific Marker in Melanoma?
Li Z; Feng J; Sun X
J Clin Oncol; 2015 Nov; 33(31):3673-4. PubMed ID: 26240228
[No Abstract] [Full Text] [Related]
3. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
4. [Colon tumor and inflammation: is C-reactive protein possible colon tumor marker?].
Myung SJ
Korean J Gastroenterol; 2008 Apr; 51(4):265-8. PubMed ID: 18516007
[No Abstract] [Full Text] [Related]
5. Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.
Chasseuil E; Saint-Jean M; Chasseuil H; Peuvrel L; Quéreux G; Nguyen JM; Gaultier A; Varey E; Khammari A; Dréno B
Acta Derm Venereol; 2018 Apr; 98(4):406-410. PubMed ID: 29327065
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of detection of circulating melanoma cells in the blood.
Dutcher JP
J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
[No Abstract] [Full Text] [Related]
7. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
8. Circulating epigenetic biomarkers in melanoma.
Xin Y; Li Z; Chan MT; Wu WK
Tumour Biol; 2016 Feb; 37(2):1487-92. PubMed ID: 26662802
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF-mutant melanoma.
Sullivan RJ
Br J Dermatol; 2016 Apr; 174(4):716-7. PubMed ID: 27115584
[No Abstract] [Full Text] [Related]
10. Tumor biomarkers in melanoma.
Ugurel S; Utikal J; Becker JC
Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
[TBL] [Abstract][Full Text] [Related]
11. Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma.
Ichigozaki Y; Fukushima S; Jinnin M; Miyashita A; Nakahara S; Tokuzumi A; Yamashita J; Kajihara I; Aoi J; Masuguchi S; Zhongzhi W; Ihn H
Exp Dermatol; 2016 Jan; 25(1):67-9. PubMed ID: 26440365
[No Abstract] [Full Text] [Related]
12. Circulating biomarkers in malignant melanoma.
Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
[TBL] [Abstract][Full Text] [Related]
13. Search for melanoma markers in plasma and serum samples.
Seraglia R; Vogliardi S; Allegri G; Comai S; Lise M; Rossi CR; Mocellin S; Scalerta R; Ragazzi E; Traldi P
Eur J Mass Spectrom (Chichester); 2005; 11(3):353-60. PubMed ID: 16107750
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
Calapre L; Warburton L; Millward M; Ziman M; Gray ES
Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
[TBL] [Abstract][Full Text] [Related]
15. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Int J Biol Markers; 1994; 9(4):247-50. PubMed ID: 7836804
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma.
Saldanha G; Potter L; Shendge P; Osborne J; Nicholson S; Yii N; Varma S; Aslam MI; Elshaw S; Papadogeorgakis E; Pringle JH
J Invest Dermatol; 2013 May; 133(5):1381-4. PubMed ID: 23303460
[No Abstract] [Full Text] [Related]
17. [Some immunological findings in malignant melanoma (author's transl)].
Richter J; Král V; Duchková H; Kubíková M
Cesk Dermatol; 1980 Feb; 55(1):12-8. PubMed ID: 6965892
[No Abstract] [Full Text] [Related]
18. Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma.
Barisione G; Fabbi M; Gino A; Queirolo P; Orgiano L; Spano L; Picasso V; Pfeffer U; Mosci C; Jager MJ; Ferrini S; Gangemi R
JAMA Ophthalmol; 2015 Sep; 133(9):1013-21. PubMed ID: 26068448
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
[TBL] [Abstract][Full Text] [Related]
20. [Acral lentiginous melanoma: a slow growing tumor of the second finger].
Cellier M; Sirvain S; Fraisse T
Presse Med; 2010 Oct; 39(10):1100-2. PubMed ID: 20630700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
